Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Inorg Biochem ; 251: 112433, 2024 02.
Artículo en Inglés | MEDLINE | ID: mdl-38043136

RESUMEN

The p53 protein plays a major role in cancer prevention, and over 50% of cancer diagnoses can be attributed to p53 malfunction. p53 incorporates a structural Zn site that is required for proper protein folding and function, and in many cases point mutations can result in loss of the Zn2+ ion, destabilization of the tertiary structure, and eventual amyloid aggregation. Herein, we report a series of compounds designed to act as small molecule stabilizers of mutant p53, and feature Zn-binding fragments to chaperone Zn2+ to the metal depleted site and restore wild-type (WT) function. Many Zn metallochaperones (ZMCs) have been shown to generate intracellular reactive oxygen species (ROS), likely by chelating redox-active metals such as Fe2+/3+ and Cu+/2+ and undergoing associated Fenton chemistry. High levels of ROS can result in off-target effects and general toxicity, and thus, careful tuning of ligand Zn2+ affinity, in comparison to the affinity for other endogenous metals, is important for selective mutant p53 targeting. In this work we show that by using carboxylate donors in place of pyridine we can change the relative Zn2+/Cu2+ binding ability in a series of ligands, and we investigate the impact of donor group changes on metallochaperone activity and overall cytotoxicity in two mutant p53 cancer cell lines (NUGC3 and SKGT2).


Asunto(s)
Metalochaperonas , Proteína p53 Supresora de Tumor , Zinc , Humanos , Línea Celular Tumoral , Quelantes , Metalochaperonas/química , Especies Reactivas de Oxígeno/metabolismo , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/metabolismo , Zinc/metabolismo , Unión Proteica
2.
J Am Chem Soc ; 144(26): 11594-11607, 2022 07 06.
Artículo en Inglés | MEDLINE | ID: mdl-35749669

RESUMEN

Oxidation of a series of CrV nitride salen complexes (CrVNSalR) with different para-phenolate substituents (R = CF3, tBu, NMe2) was investigated to determine how the locus of oxidation (either metal or ligand) dictates reactivity at the nitride. Para-phenolate substituents were chosen to provide maximum variation in the electron-donating ability of the tetradentate ligand at a site remote from the metal coordination sphere. We show that one-electron oxidation affords CrVI nitrides ([CrVINSalR]+; R = CF3, tBu) and a localized CrV nitride phenoxyl radical for the more electron-donating NMe2 substituent ([CrVNSalNMe2]•+). The facile nitride homocoupling observed for the MnVI analogues was significantly attenuated for the CrVI complexes due to a smaller increase in nitride character in the M≡N π* orbitals for Cr relative to Mn. Upon oxidation, both the calculated nitride natural population analysis (NPA) charge and energy of molecular orbitals associated with the {Cr≡N} unit change to a lesser extent for the CrV ligand radical derivative ([CrVNSalNMe2]•+) in comparison to the CrVI derivatives ([CrVINSalR]+; R = CF3, tBu). As a result, [CrVNSalNMe2]•+ reacts with B(C6F5)3, thus exhibiting similar nucleophilic reactivity to the neutral CrV nitride derivatives. In contrast, the CrVI derivatives ([CrVINSalR]+; R = CF3, tBu) act as electrophiles, displaying facile reactivity with PPh3 and no reaction with B(C6F5)3. Thus, while oxidation to the ligand radical does not change the reactivity profile, metal-based oxidation to CrVI results in umpolung, a switch from nucleophilic to electrophilic reactivity at the terminal nitride.


Asunto(s)
Cromo , Electrones , Espectroscopía de Resonancia por Spin del Electrón , Ligandos , Metales , Oxidación-Reducción
3.
Dalton Trans ; 48(35): 13326-13336, 2019 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-31429839

RESUMEN

A tridentate benzoxazole-containing aminophenol ligand NNOH2 was coordinated to Co and V metal centers and the electronic structure of the resultant complexes characterized by both experimental and theoretical methods. The solid state structure of the Co complex exhibits a distorted octahedral geometry with two tridentate ligands bound in meridional fashion, and coordination-sphere bond lengths consistent with a Co(iii) oxidation state. EPR and magnetic data support a S = 1/2 ground state, and a formal electronic description of Co(iii)(NNOAP)(NNOISQ) where NNOAP corresponds to an amidophenoxide and NNOISQ to the iminosemiquinone redox level. However, the metrical parameters are similar for both ligands in the solid state, and DFT calculations support delocalization of the ligand radical over both ligands, affording an intermediate ligand redox level Co(iii)(NNO1.5-)(NNO1.5-). The vanadyl complex exhibits a distorted octahedral geometry in the solid state consistent with a V(v) metal center and amidophenoxide (NNOAP), acetylacetonate and oxo ligands. The ligand metrical parameters are consistent with significant amidophenoxide to V(v) π donation. Overall, our results highlight the roles of electron transfer, delocalization, and π bonding in the metal complexes under study, and thus the complexity in assignment of the electronic structure in these systems.

4.
Chem Sci ; 10(46): 10802-10814, 2019 Dec 14.
Artículo en Inglés | MEDLINE | ID: mdl-32055386

RESUMEN

Protein misfolding and aggregation contributes to the development of a wide range of diseases. In cancer, over 50% of diagnoses are attributed to p53 malfunction due to missense mutations, many of which result in protein misfolding and accelerated aggregation. p53 mutations also frequently result in alteration or loss of zinc at the DNA-binding site, which increases aggregation via nucleation with zinc-bound p53. Herein, we designed two novel bifunctional ligands, LI and LH , to modulate mutant p53 aggregation and restore zinc binding using a metallochaperone approach. Interestingly, only the incorporation of iodine function in LI resulted in modulation of mutant p53 aggregation, both in recombinant and cellular environments. Native mass spectrometry shows a protein-ligand interaction for LI , as opposed to LH , which is hypothesized to lead to the distinct difference in the p53 aggregation profile for the two ligands. Incorporation of a di-2-picolylamine binding unit into the ligand design provided efficient intracellular zinc uptake, resulting in metallochaperone capability for both LI and LH . The ability of LI to reduce mutant p53 aggregation results in increased restoration of p53 transcriptional function and mediates both caspase-dependent and -independent cell death pathways. We further demonstrate that LI exhibits minimal toxicity in non-cancerous organoids, and that it is well tolerated in mice. These results demonstrate that iodination of our ligand framework restores p53 function by interacting with and inhibiting mutant p53 aggregation and highlights LI as a suitable candidate for comprehensive in vivo anticancer preclinical evaluations.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA